09/11/2025 | Press release | Distributed by Public on 09/11/2025 15:50
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (right to buy) | $2.73 | 09/10/2025 | M | 1,278 | (3) | 08/23/2028 | Common Stock | 1,278 | $ 0 | 0 | D | ||||
Stock Option (right to buy) | $3.3 | 09/10/2025 | M | 4,578 | (4) | 06/04/2030 | Common Stock | 4,578 | $ 0 | 1,291 | D | ||||
Stock Option (right to buy) | $3.3 | 09/10/2025 | M | 7,045 | (5) | 06/04/2030 | Common Stock | 7,045 | $ 0 | 0 | D | ||||
Stock Option (right to buy) | $13.23 | 09/10/2025 | M | 7,674 | (6) | 04/21/2031 | Common Stock | 7,674 | $ 0 | 4,969 | D | ||||
Stock Option (right to buy) | $2.07 | 09/10/2025 | M | 252 | (7) | 06/05/2028 | Common Stock | 252 | $ 0 | 12 | D | ||||
Stock Option (right to buy) | $2.07 | 09/10/2025 | M | 291 | (7) | 06/05/2028 | Common Stock | 291 | $ 0 | 0 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Neagle Matthew 411 FIRST AVENUE SOUTH SUITE 501 SEATTLE, WA 98104 |
Chief Operating Officer |
/s/Matthew Cullen as Attorney-in-fact for Matthew Neagle | 09/11/2025 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The reporting person used some of the proceeds from the sale of the issuer's shares of common stock to fund the exercise of the options disclosed in Table II. |
(2) | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.65 to $18.76 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
(3) | The stock options vested as follows: (i) 25% of the award vested on July 1, 2019 and (ii) the remainder of the award vested in 36 equal monthly installments thereafter. |
(4) | The stock options vested as follows: (i) 25% of the award vested on September 1, 2020, with 25% of the award vesting in 6 equal monthly installments thereafter and (ii) 25% of the award vested March 1, 2021, with the remaining 25% of the award vesting in 36 equal monthly installments thereafter. |
(5) | The stock options vested as follows: (i) 25% of the award vested March 1, 2020, (ii) 25% of the award vested on March 1, 2021, and (iii) the remainder of the award vested in 36 equal monthly installments thereafter. |
(6) | The stock options vested as follows: (i) 25% of the award vested December 31, 2020, (ii) 25% of the award vested on December 31, 2021, and (iii) the remainder of the award vested in 35 equal monthly installments thereafter. |
(7) | The stock options vested as follows: (i) 25% of the award vested on April 1, 2019 and (ii) the remainder of the award vested in 36 equal monthly installments thereafter. |